RATIONALE: Dopamine (DA) in the ventral striatum (VST) has long been implicated in addiction pathologies, yet its role in temporal decision-making is not well-understood. OBJECTIVES: To determine if VST DA D2 receptor availability corresponds with greater impulsive choice in both nontreatment-seeking alcoholics (NTS) and social drinkers (SD). METHODS: NTS subjects (n = 10) and SD (n = 13) received PET scans at baseline with the D2/D3 radioligand [(11)C]raclopride (RAC). Outside the scanner, subjects performed a delay discounting procedure with monetary rewards. RAC binding potential (BPND) was estimated voxelwise, and correlations were performed to test for relationships between VST BPND and delay discounting performance. Self-reported impulsivity was also tested for correlations with BPND. RESULTS: Across all subjects, greater impulsive choice for $20 correlated with lower BPND in the right VST. NTS showed greater impulsive choice than SD and were more impulsive by self-report. Across all subjects, the capacity of larger rewards to reduce impulsive choice (the magnitude effect) correlated negatively (p = 0.028) with problematic alcohol use (AUDIT) scores. Self-reported impulsivity did not correlate with BPND in VST. CONCLUSIONS: Preference for immediate reinforcement may reflect greater endogenous striatal DA or lower D2 number, or both. Alcoholic status did not mediate significant effects on VST BPND, suggesting minimal effects from alcohol exposure. The apparent lack of BPND correlation with self-reported impulsivity highlights the need for objective behavioral assays in the study of the neurochemical substrates of behavior. Finally, our results suggest that the magnitude effect may be more sensitive to alcohol-induced problems than single discounting measures.
RATIONALE: Dopamine (DA) in the ventral striatum (VST) has long been implicated in addiction pathologies, yet its role in temporal decision-making is not well-understood. OBJECTIVES: To determine if VST DA D2 receptor availability corresponds with greater impulsive choice in both nontreatment-seeking alcoholics (NTS) and social drinkers (SD). METHODS:NTS subjects (n = 10) and SD (n = 13) received PET scans at baseline with the D2/D3 radioligand [(11)C]raclopride (RAC). Outside the scanner, subjects performed a delay discounting procedure with monetary rewards. RAC binding potential (BPND) was estimated voxelwise, and correlations were performed to test for relationships between VST BPND and delay discounting performance. Self-reported impulsivity was also tested for correlations with BPND. RESULTS: Across all subjects, greater impulsive choice for $20 correlated with lower BPND in the right VST. NTS showed greater impulsive choice than SD and were more impulsive by self-report. Across all subjects, the capacity of larger rewards to reduce impulsive choice (the magnitude effect) correlated negatively (p = 0.028) with problematic alcohol use (AUDIT) scores. Self-reported impulsivity did not correlate with BPND in VST. CONCLUSIONS: Preference for immediate reinforcement may reflect greater endogenous striatal DA or lower D2 number, or both. Alcoholic status did not mediate significant effects on VST BPND, suggesting minimal effects from alcohol exposure. The apparent lack of BPND correlation with self-reported impulsivity highlights the need for objective behavioral assays in the study of the neurochemical substrates of behavior. Finally, our results suggest that the magnitude effect may be more sensitive to alcohol-induced problems than single discounting measures.
Authors: Karmen K Yoder; Daniel S Albrecht; David A Kareken; Lauren M Federici; Kevin M Perry; Elizabeth A Patton; Qi-Huang Zheng; Bruce H Mock; Sean J O'Connor; Christine M Herring Journal: Eur J Nucl Med Mol Imaging Date: 2011-10-19 Impact factor: 9.236
Authors: Andreas Heinz; Thomas Siessmeier; Jana Wrase; Derik Hermann; Sabine Klein; Sabine M Grüsser; Sabine M Grüsser-Sinopoli; Herta Flor; Dieter F Braus; Hans Georg Buchholz; Gerhard Gründer; Mathias Schreckenberger; Michael N Smolka; Frank Rösch; Karl Mann; Peter Bartenstein Journal: Am J Psychiatry Date: 2004-10 Impact factor: 18.112
Authors: Zhipeng Cao; Jonatan Ottino-Gonzalez; Renata B Cupertino; Nathan Schwab; Colin Hoke; Orr Catherine; Janna Cousijn; Alain Dagher; John J Foxe; Anna E Goudriaan; Robert Hester; Kent Hutchison; Chiang-Shan R Li; Edythe D London; Valentina Lorenzetti; Maartje Luijten; Rocio Martin-Santos; Reza Momenan; Martin P Paulus; Lianne Schmaal; Rajita Sinha; Zsuzsika Sjoerds; Nadia Solowij; Dan J Stein; Elliot A Stein; Anne Uhlmann; Ruth J van Holst; Dick J Veltman; Reinout W Wiers; Murat Yücel; Sheng Zhang; Neda Jahanshad; Paul M Thompson; Patricia Conrod; Scott Mackey; Hugh Garavan Journal: Addict Biol Date: 2021-01-28 Impact factor: 4.280
Authors: Natalia Jaworska; Sylvia M Cox; Kevin F Casey; Isabelle Boileau; Mariya Cherkasova; Kevin Larcher; Alain Dagher; Chawki Benkelfat; Marco Leyton Journal: PLoS One Date: 2017-03-27 Impact factor: 3.240
Authors: Todd Zorick; Kyoji Okita; Mark A Mandelkern; Edythe D London; Arthur L Brody Journal: Int J Neuropsychopharmacol Date: 2019-04-01 Impact factor: 5.176
Authors: Jaime J Castrellon; Kendra L Seaman; Jennifer L Crawford; Jacob S Young; Christopher T Smith; Linh C Dang; Ming Hsu; Ronald L Cowan; David H Zald; Gregory R Samanez-Larkin Journal: J Neurosci Date: 2018-11-16 Impact factor: 6.167
Authors: Martine M Groefsema; Rutger C M E Engels; Valerie Voon; Arnt F A Schellekens; Maartje Luijten; Guillaume Sescousse Journal: Addict Biol Date: 2019-05-07 Impact factor: 4.280